Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 7/2007

01-07-2007 | Letter to the Editor

Multiple myeloma of the liver presenting as non-obstructive jaundice

Authors: Ch. Ben Taarit, H. Ajlani, F. Fareh, R. Zermani, S. Ben Jilani, W. Gharbi, H. Ben Maiz, A. Khedher

Published in: Annals of Hematology | Issue 7/2007

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Barlogie B, Smallwood L, Smith T, Alexanian R (1989) High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma. Ann Intern Med 110(7):521–525PubMed
2.
Murakami H, Takada S, Hatsumi N, Yokohama A, Saitoh T, Uchiumi H, Maehara T et al (2000) Multiple myeloma presenting high fever and serum levels of lactic dehydrogenase, CRP, and interleukin-6. Am J Hematol 64(1):76–77PubMedCrossRef
3.
Pastor E, Perella M, Gomez A, Grau E, Pérez A, Escandon J (1996) Multiple myeloma of the liver presenting as nonobstructive jaundice. Am J Hematol 53:205–206PubMedCrossRef
4.
Arebi N, Patel B, Aqel NM, Pitcher MCL (2004) Ig a multiple myeloma presenting as non-obstructive jaundice. Postgrad Med J 80:489–490PubMedCrossRef
5.
Abu-Hammour AM, Venu RP, Etzkorn KP, Showel JL, Jaytzev PM, Brown RD (1996) Common bile duct obstruction caused by multiple myeloma of the pancreas. Gastrointest Endosc 44:606–608PubMedCrossRef
6.
Lake G, Scharde R, Van Thiel D (1983) Extrahepatic biliary tract obstruction due to plasmocytoma. J Clin Gastroenterol 5:273–276PubMedCrossRef
7.
James A, Calomeni J, Smith R (1985) Obstructive jaundice from hepatic amyloidosis in patient with multiple myeloma. Am J Hematol 19:277–279CrossRef
Metadata
Title
Multiple myeloma of the liver presenting as non-obstructive jaundice
Authors
Ch. Ben Taarit
H. Ajlani
F. Fareh
R. Zermani
S. Ben Jilani
W. Gharbi
H. Ben Maiz
A. Khedher
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0267-9

Other articles of this Issue 7/2007

Annals of Hematology 7/2007 Go to the issue

Letter to the Editor

Secondary myelodysplastic syndrome after hydroxychloroquine therapy

Letter to the Editor

Profuse erythema multiforme induced by chlorambucil

Original Article

Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry

Letter to the Editor

Imatinib-induced Stevens–Johnson syndrome: recurrence after re-challenge with a lower dose

Original Article

Status of HFE mutation in thalassemia syndromes in north India

Letter to the Editor

Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits